| Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives T Mocan, Z Sparchez, R Craciun, CN Bora, DC Leucuta Clinical and Translational Oncology 21 (6), 702-712, 2019 | 53 | 2019 |
| Contemporary role of liver biopsy in hepatocellular carcinoma Z Sparchez, T Mocan World journal of hepatology 10 (7), 452, 2018 | 49 | 2018 |
| Assessing the impact of COVID-19 on liver cancer management (CERO-19) S Muñoz-Martínez, V Sapena, A Forner, JC Nault, G Sapisochin, ... JHEP reports 3 (3), 100260, 2021 | 48 | 2021 |
| Extracellular vesicles in liver diseases: diagnostic, prognostic, and therapeutic application SK Urban, T Mocan, H Sänger, V Lukacs-Kornek, M Kornek Seminars in liver disease 39 (01), 070-077, 2019 | 48 | 2019 |
| Liquid biopsies in hepatocellular carcinoma: Are we winning? T Mocan, AL Simão, RE Castro, CMP Rodrigues, A Słomka, B Wang, ... Journal of Clinical Medicine 9 (5), 1541, 2020 | 47 | 2020 |
| Prognostic Factors after Percutaneous Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma. Impact of Incomplete Ablation on Recurrence and Overall Survival Rates. Z Sparchez, T Mocan, P Radu, LP Mocan, M Sparchez, DC Leucuta, ... Journal of Gastrointestinal & Liver Diseases 27 (4), 2018 | 44 | 2018 |
| Contrast enhanced ultrasonography in assessing the treatment response to transarterial chemoembolization in patients with hepatocellular carcinoma. Z Spârchez, T Mocan, P Radu, O Anton, N Bolog Medical Ultrasonography 18 (1), 96-102, 2016 | 27 | 2016 |
| Viscoelastic tests in liver disease: where do we stand now? A Buliarca, A Horhat, T Mocan, R Craciun, B Procopet, Z Sparchez World Journal of Gastroenterology 27 (23), 3290, 2021 | 24 | 2021 |
| Synergistic effects of extracellular vesicle phenotyping and AFP in hepatobiliary cancer differentiation SK Urban, H Sänger, M Krawczyk, H Julich‐Haertel, A Willms, J Ligocka, ... Liver International 40 (12), 3103-3116, 2020 | 24 | 2020 |
| Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular carcinoma T Mocan, M Ilies, I Nenu, R Craciun, A Horhat, R Susa, I Minciuna, I Rusu, ... International immunopharmacology 94, 107467, 2021 | 22 | 2021 |
| Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how? T Mocan, A Horhat, E Mois, F Graur, C Tefas, R Craciun, I Nenu, ... World Journal of Gastrointestinal Oncology 13 (12), 2050, 2021 | 21 | 2021 |
| EVs as potential new therapeutic tool/target in gastrointestinal cancer and HCC A Słomka, T Mocan, B Wang, I Nenu, SK Urban, MA Gonzalez-Carmona, ... Cancers 12 (10), 3019, 2020 | 19 | 2020 |
| Percutaneous ultrasound guided radiofrequency and microwave ablation in the treatment of hepatic metastases. A monocentric initial experience. Z Sparchez, T Mocan, NA Hajjar, A Bartos, C Hagiu, D Matei, R Craciun, ... Medical Ultrasonography 21 (3), 217-224, 2019 | 18 | 2019 |
| Hepatic Hydrothorax—An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis D Matei, R Craciun, D Crisan, B Procopet, T Mocan, S Pasca, R Zaharie, ... Journal of Clinical Medicine 10 (16), 3688, 2021 | 16 | 2021 |
| Ultrasound or sectional imaging techniques as screening tools for hepatocellular carcinoma: fall forward or move forward? Z Sparchez, R Craciun, C Caraiani, A Horhat, I Nenu, B Procopet, ... Journal of Clinical Medicine 10 (5), 903, 2021 | 15 | 2021 |
| Real-time contrast-enhanced–guided biopsy compared with conventional ultrasound–guided biopsy in the diagnosis of hepatic tumors on a background of advanced chronic liver … Z Sparchez, T Mocan, C Hagiu, G Kacso, T Zaharie, I Rusu, N Al Hajjar, ... Ultrasound in medicine & biology 45 (11), 2915-2924, 2019 | 15 | 2019 |
| Hepatocellular Carcinoma Occurrence and Recurrence after Antiviral Treatment in HCV-Related Cirrhosis. Are Outcomes Different after Direct Antiviral Agents? A Review. Z Spârchez, T Mocan Journal of Gastrointestinal & Liver Diseases 26 (4), 2017 | 13 | 2017 |
| Outcome of liver cancer patients with SARS‐CoV‐2 infection: an international, multicentre, cohort study S Muñoz‐Martínez, V Sapena, A Forner, J Bruix, M Sanduzzi‐Zamparelli, ... Liver international 42 (8), 1891-1901, 2022 | 12 | 2022 |
| Microwave ablation in the treatment of liver tumors. A better tool or simply more power? Z Sparchez, T Mocan, P Radu, I Nenu, M Comsa, N Al Hajjar, E Mois, ... Medical ultrasonography 22 (4), 451-460, 2020 | 12 | 2020 |
| Extracellular Vesicles and Circulating Tumour Cells-complementary liquid biopsies or standalone concepts? A Słomka, B Wang, T Mocan, A Horhat, AG Willms, IGH Schmidt-Wolf, ... Theranostics 12 (13), 5836, 2022 | 11 | 2022 |
Rareş Crăciun"Prof. Dr. Octavian Fodor" Regional Institute of Gastroenterology and Hepatology, Cluj Napoca, ROVerified email at elearn.umfcluj.ro
